Pharm 2 Flashcards
bactericidal drugs
penicillins cephalosporins aminoglycosides vancomycin aztreonam imipenem fluroroquinolones metronidazole polymyxins quinupristin-dalfopristin bacitracin
bacteriostatic drugs
erythromycin (macrolides) clindamycin tetracycline chloramphenicol sulfonamides trimethoprim nitrofurantoin
narrow spectrum
only G+ or G-: isoniazid against mycobacterium
extended spectrum
G+, some G- i.e. ampicillin
broad spec
wide variety of G+ and G-: tetracycline, chloramphenicol, imipenem
expense of drug administration
IV>IM>oral (cheapest)
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): natural penicillins
G, V Potassium, G Procaine, G Benzathine, G Benzathine + Penicillin G Procaine
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): Penicillinase resistant Penicillins (anti-staph)
methicillin
nafcillin
oxacillin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): ext. spec PNC
ampicillin
amoxicillin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): antipseudomonal
Ticarcillin + clavulanate potassium (Timentin)
Piperacillin + Tazobactam (Zosyn)
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): monobactams
aztreonam
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): carbapenems
Imipenem + Cilastatin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): B-lactamase inhibitors
Clavulanic acid, Tazobactam
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 1st gen
Cefazolin
Cephalexin
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 2nd gen
Cefaclor
Cefoxitin
Cefuroxime
Cefprozil
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 3rd gen
Ceftriaxone
Cefixime
Cefotaxime
Ceftazidime
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 4th gen
Cefepime
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 5th gen
Ceftaroline
other drugs that inhibit bacterial cell wall synthesis
vancomycin
bacitracin
drugs that alter cell membrane permeability
Polymyxin B
Daptomycin
drugs that inhibit bacterial protein synthesis: Tetracyclines
short-acting: Tetracycline
long-acting: Doxycycline, Minocycline
new: Tigecycline
drugs that inhibit bacterial protein synthesis: Macrolides
Erythromycin base " Estolate, " Stearate, " Ethylsuccinate, " Lactobionate Clarithromycin Azithromycin Telithromycin
drugs that inhibit bacterial protein synthesis: Aminoglycosides
Gentamicin; generic: Garamycin, Jenamicin Tobramycin; generic: Nebcin Amikacin; generic: Amikin Streptomycin Neomycin
drugs that inhibit bacterial protein synthesis: Misc.
Clindamycin
Quinupristin/Dalfopristin
Linezolid
act on 50S ribosomal subunit
Cloramphenicol, macrolides, clindamycin, quinupristin/dalfopristin, linezolid
act on 30S ribosomal subunit
Aminoglycosides, Tetracyclines
drugs that act as anti-metabolites: Sulfonamindes
Silver Sulfadiazine (SILVADINE): topical Trimethoprim-sulfamethoxazole
drugs that inhibit nucleic acid synthesis: Fluoroquinolones
Ciprofloxacin (CIPRO)
Levofloxacin (LEVAQUIN)
Moxifloxacin (AVELOX)
Misc. drugs that act via nucleic acids
Metronidazole
Nitrofurantoin
Rifampin
empirical therapy
“best guess” therapy, br. spec/combo abx
guided by Gs, site of inf, clinical experience, local hospital antibiogram susc. reports
-should be changed to rational therapy (narrow spec) when susc. tests performed and org. ID’d
epsilometer (E) test:
also determines MIC, plastic strip containing gradient of known conc. abc placed on agar plate containing pt’s bac. isolate
how to monitor antimicrobial activity in vivo
serum inhibitory titer: greatest dilution of pt’s serum that inhibits visible growth of pt’s infecting pathogen
bactericidal titer: plate out above no-growth samples onto abx-free plates
min. drug conc. at infected site should be..
> = MIC, ideally 2-4x MIC
abscesses must be drained
BBB may prevent..
penetration of drug into CSF
-but during infection BBB is diminished (opened up tight junctions of cerebral capillaries)–>inc. penetration
this may prevent abx penetration to site of action (and dec. levels of free drug)
abx binding to plasma proteins
med doses may need to be adjusted for..
renal/hepatic failure
newborns
oral vs. parenteral admin
bactericidal or bacteriostatic?
cidal is better, esp. if immunecomp
strains of these are resistant to all known drugs
Enterococci
Pseudomonas
Enterobacter
bacterial resistance factors
indiscrim. use (misuse)
delay in optimal tx
admin of subopt. dose
tx during dormant stage
inability to reach inf. site (CNS, eye, prostate, abscess)
defective funct. status of host defense mech
agricult. used of abx in livestock
how microorganisms produce resistance
mutation and selection
i. e. resistance to:
- strep (ribosomal mut.)
- quinolone (DNA gyrase)
- linezolid (rRNA)
- rifampin (RNA polymerase)
- M. tuberculosis
resistance mediated by genetic exchange
HGT:
transformation (PCN res. in pneumo.)
transduction (Staph, penicillinase)
conjugation
conjugation
2 sets of genes transferred: R-determinant (resistance) and resistance transfer factor (RTF)–>ind or combine to for R-factor
- can have >1 abx resis. gene!
- *>50% ppl have int. bac containing R-factors
transposon
DNA sequences that can “jump from place to place”, can carry drug resis. genes
plasmid–>plasmid
plasmid–>chromosome (and vis versa)
biochem mechs of drug resistance
- dec. perm. of org to drug: porins do not allow in anymore (G-) OR active efflux (tetras)
- inactivation of abx by enzymes: (PCN, Chloramphenicol, Aminoglycosides): B-lactamases (+ and -) acetyl/phosphoryl/adenylate drug (amino glycosides, G-)
- altered drug target site: PBP w/ altered affinity for drug, mut. in FQ target (DNA gyrase)
forms of synergism seen with combo abx tx
- block of seq. steps in metabolic pathway (Trimethoprim + Sulfamethosazole–>folic acid)
- inhib. enz. inact. of abx (B-lactamase inhibitor)
- enhanced abx uptake by bac (aminoglycoside + B-lactam)
synergism
4x or greater reduction in MIC or MBC when drug combined
antagonism
> 50% MIC of each drug needed to produce inhibition of growth
antagonism exs.
bacteriostatic antags. bactericidal (need actively growing org) (PCN + chlortetracycline)
induction of enz. inact.: imipenem (induces B-lactamase) + piperacillin (susc. to B-lactamase)
combo abx tx uses
mixed bac inf
unknown specific cause-empirical tx (i.e. pneumonia: macrolides for M. pneumo + ceftriaxone for G-)
synergism may be nec. to kill org. (PCN + AMGS better tx for enterococcal endocarditis)
may prevent resistances (bismuth salts + amos/tetra/or clarithro + metronidazole for H. pylori)
disadv. of combo abx tx
inc. toxic side effects
selection of orgs resis. to >1 abx
possible antag. effect if wrong combo
abx ppx
- post-exposure to certain microorgs: gon, syph, anthrax
- prevent recurrent dis. in susc. pt: artific. heart valve undergoing dental proc. to prevent bac endocarditis, emphysema pts to prevent chron. bronchitis, frequent UTIs
- surgical procedures: 0-2 hrs before, during, 3-4 hrs after
- trauma contam wounds
abx ppx approved surgical procedures
contam, clean-contam operations, dirty wounds, prosthetic placement, immune comp host (any proc)
superinfections
new infection appears during chemotx for other infection
why do superinfections occur?
doses of abx can inhibit NF growth–>other orgs uninhibited
superinfection orgs
enterobacteriaceae, pseudomonas, candida, fungi
inc. risk of superinfection w/
brd spec abx, longer course, oral admin over IM/IV
abx misuse
- for viral infection (fever 2 wks which could be tb, intra-abd. abscess, inf. endocarditis, Ca
- undetermined cause (NOT antipyretics)
- improp. dosage
- abx has to reach inf. site (get rid of pus and kidney stones)
- lack of adeq. bac info: more testing!
- improp. duration of tx (finish your abxs!)
receptors at parasympathetic end organs (and symp. sweat glands)
muscarinic: M1-5, 2,3*most common
B1 adrenergic receptor
heart (inc. force, rate)
kidney (mediate renin secr)
brain
B2 adrenergic receptor
airway, BVs of skel music, pregnant uterus
-smooth musc relaxation
B3 adrenergic receptor
bladder smooth musc: relaxation
a1 adrenergic receptor
most BVs, urinary sphincters, eye
-mediate contraction of smooth musc
a2 adrenergic receptor
some end organs, @ adrenergic nerve endings and in CNS
organs that received both parasym and symp innervation
heart, GI, bladder, eye, etc
organs w/ only symp innervation
adrenal medulla, spleen capsule, pilomotor musc, BVs of skin and skeletal muscd
reserpine blocks adrenergic system..
produces exaggerated cholinergic response: inc. GI motility, secretions
atropine blocks cardiac vagal influence..
cardiac acceleration, reduction of GI motility, secretion
eye sympathetics
a1: mydriasis (dilator musc. of iris)
B2: inc. aqueous humor
gland sympathetics
a, B
B2: respiratory secretions
heart sympathetics
B1, B2:
inc. rate (SA node), contractility (ventricles), automaticity, conduction velocity (SA, AV nodes)
BVs sympathetics (mucosa, saliva, skin, splanchnic)
a1, a2: constriction
BVs sympathetics (skeletal musc)
a1: constriction
B2: dilation
BVs parasyms
no PS inn to most vasc beds, but muscarinic rec are present on endo cells: activation of these receptors: NO-med. vasodilation
airway symps
relaxation: B2
GI symps
relaxation: a1, a2, B1, B2
dec. motility
Urinary bladder wall, sphincter, prostate sympathetics
relaxation: B2, B3 (widens out)
contraction: a1 (sphinter)
kidney JG cell symp
inc. renin secretion: B1
uterus symp
contraction: a1
relaxation: B2 (later on)
male sex organs symp
ejaculation: a1
male sex organs PS
erection
liver, fat cells symp
inc. glucose output: B2
inc. FA output: B1
skin pilomotor music and sweat glands symps
contraction: a1
secretion: muscarinic
eye PS
miosis (pupillary sphincter musc)
accommodation- near vision (ciliary musc.)
PS ciliary musc contraction also…
inc. pressure on trabecular meshwork–>inc. outflow of AH in canal of Schlemm and dec. intraocular pressure
PS action on lacrimal gland
inc. tear production
acetylcholine is formed by action of
choline acetyl transferse (choline + acetate)
ACh pathway
stored in vesicles–>AP–>inc. IC [CA2+]–>storage vesicle fuses with plasma mem–>ACh rel. into synapse–>acts on postmen. rec–>activates transduction pathway–>response
nicotinic rec. usually coupled to
Na+ channels
muscarinic rec may be coupled to
phospholipase C, K+ channels
or act thru G-protein mechanism to inhibit adenylate cyclase
actions of ACh terminated by
acetycholinesterase (rapid hydrolysis) choline and acetate recycle to ACh by presyn. nerve ending
specific sites where drugs can modify cholinergic system
- ACh synthesis
- ACh release
- stim or blockade of postmen. receptors
- inhib. of AChesterase
tyrosine–>DOPA–>DA–>NE
- tyrosine hydroxylase* 2. DOPA decarboxylase 3. Dopamine B-hydroxylase
NE acts on postsyn. rec
a1 or B1–>signal transduction pathway
–>response
Noradrenergic signal transduction pathway
typ. involve G-prot. coupled rec.
B-rec: coupled to adenylate cyclase
a-rec: coupled to pholspholipases or ion channels
NE can also act on
a2 rec on presynaptic nerve ending: feedback inhibition on NE release
action of NE terminated mostly by
rapid reuptake into presyn. nerve ending, med. by high affinity transport pump–>broken down by MAO or requestered in storage vesicles
sites of pharm intervention on Noradrenergic system
- synth, storage, del of NE
- stim or block of postsyn a1, B1, B2
- stim or block of presyn a2 rec
- inhib of NE reuptake
- inhib of NE metab by MAO
direct acting muscarinic agonists
acetycholine (Miochol-E) carbachol (Isopto Carbachol) methacholine (Provocholine) bethanechol (Urecholine) pilocarpine (Salagen/Ocusert Pilo) cevimeline (Evoxac)
indirect acting drugs: cholinesterase inhibitors -reversible
edrophonium (Tensilon) physostigmine/eserine neostigmine (Prostigmin) pyridostigmine (Mestinon) rivastigmine (Exelon) donepezil (Aricept) carbamate insecticides (Carbaryl)
indirect acting drugs: cholinesterase inhibitors-irreversible
DFP/diisopropylfurophosphate/isoflurophate and echothiophate
organophasphate insecticides (Parathion, Malathion)
nerve gases in chem warfare (Sarin, soman, Tabun, Vx)
indirect acting drugs: cGMP phosphodiesterase (PDE-5) inhibitors
sildenafil (Viagra)
vardenafil (Levitra)
tadalafil (Cialis)
Cholinesterase Reactivator
pralidoxime/2-PAM (Protopam)
Toxins
botulinum toxin (BOTOX)
Muscarinic ANTAGONISTS (anticholinergics)
atropine (hyoscyamine) and homatropine scopolamine and methscopolamine dicyclomine (Bentyl) propantheline glycopyrrolate (Robinul) ipratropium (Atrovent) tiatropium (Spiriva) benztropine (Cogentin) trihexyphenidyl (Artane) tolterodine (Detrol) oxybutynin (Ditropan) solifenacin (VESIcare) tropicamide (Mydriacyl)
Botulinum toxin (BOTOX) acts by
inhib. syn/rel of ACh
M1 rec
in symp. gang and myenteric plexus, unclear function
possibly stomach: med gastric acid sec
M2 rec
located in heart, some smooth musc
M3 rec
glands, smooth musc, BVs
ACh stimulated muscarinic rec in what kind of manner
dose/conc. dependent, relatively nonselective
Nm vs Nn rec.
Nm rec. located on sk. music at NM junc, Nn rec. located in autonom ganglia and adrenal medulla
at low/mod doses ACh…
at high doses…
-stim both types nicotinic receptor
-desensitizes rec at high conc.–>gang. blockade, muscle paralysis
(in contrast to muscarinic: no desensitization, just plateau)
PS heart
atria, SA node, AV node, minor to ventricles
- dec. HR by slowing firing of SA nodal pacemaker cells and slowing AV conduction
- only min. effects on ventricular contractility and automaticity
PS BVs
not inn. by PS, but endothelial cells in most BVs do contain muscarinic rec., stim. by ACh or muscarinic agonists–>NO (cGMP) med vasodilation–>dec. in BP
-enhanced by cholinesterase inhibs like edrophonium, blocked by muscarinic antagonists such as atropine
BVs that receive more PS inn.
corpus cavernosum, some cerebral, coronary, skeletal musc. BVs
PS eye
pupillary constrictor muscles: miosis
ciliary muscle: accommodation
-lowered IOP (outflow of AH)
PS smooth muscle
bladder, stomach, sm. intestine, bowel, etc.
-typ. stim. contraction of sm. musc to increase motility
PS glands
salivary, lacrimal, mucosa of GI, airway, etc.
-stimulate secretions (muscarinic ANTAGONISTS have drying effect)
PS airways
bronchoconstriction and inc. respiratory secretions
-
Muscarinic ANTAGONISTS useful in asthma tx
ipratropium (Atrovent) tiatropium (Spiriva)
muscarinic agonist or cholinesterase inhibs. can aggravate asthma
PS GI
stimulate GI motility and secretion
also reg by “enteric NS”
PS NM junction
ACh released by motor neurons can act on nicotinic rec. at motor end plate to cause musc. contraction
- receptors are DESENSITIZED if excess ACh (i.e. high dose cholinesterase inhib.)–>musc. paralysis
- exogenously admin. ACh has little effect on skel. musc.
- nicotinic effects can be inhib by ganglionic and NM blockers
direct acting muscarinic agonist activity
inc. GI motility, secretion
dec. HR
dec. BP due to dec. CO and direct vasodilation
contraction of bladder, relax. of ur. sphincters
miosis and dec. IOP
stim of secretions
adverse effects of muscarinic stimulation
hypotension, bradycardia, chronchoconstriction, diarrhea, cramping, urinary incontinence, excessive sweating, salivation
major tx uses of muscarinic agonists
promote GI motility (bethanechol)
tx urinary retention (bethanechol)
tx of glaucoma (pilocarpine, acetylcholine, carbachol)
tx of sal. gland dysfunc (pilocarpine, cevimeline)
pulmonary function testing in asthma (methacholine)- dangerous dx test
when muscarinic agonists are contraindicated/used w/ caution
asthma, bradycardia, hypotension, vasomotor instability, CAD, peptic ulcer disease, hyperthyroidism, weakened smooth musc of bladder/GI, urinary/intestinal obstruction
DO NOT give choinesters..
IV or IM, but rather subQ, orally, topically(eye)
acetylcholine
limited, tx for glaucoma
–>rapidly hydrolyzed by pseudocholinesterase in plasma
carbachol
analog of ACh, resistant to hydrolysis
- stim both muscarinic and nicotinic
- topically for glaucoma
methacholine
ACh analog, stim muscarinic (little nicotinic effect)
used in asthma pulmonary function testing
bethanechol (Urecholine)
ACh analog, resis to hydrolysis, direct muscarinic agonist (little nicotinic effect)
stim. GI motility and tx for urinary retention
pilocarpine (Salagen, Ocusert Pilo)
muscarinic agonist, tx for glaucoma and xerostomia (dry mouth) due to poor salivary secretion
cevimeline (Evoxac)
muscarinic agonist, tx for salivary gland dysfunction
muscarine
natural in mushrooms (Inocybe and Clitocybe)
- salivation, lacrimation, nausea, extreme GI hypermotility, bronchospasm, bradycardia, hypotension, shock
- can be tx with high dose atropine (1-2 mg IM every 30 min)
cholinesterase inhibitors have similar effects as muscarinic agonists, plus
stimulation of skeletal muscle–>paralysis of skeletal muscles @ toxic doses
toxic effects of cholinesterase inhibitors (cholinergic crisis)
i. e. organophosphate insecticide/nerve gase poisoning
- SLUDGE (salivation, lacrimation, urination, defection, GI distress, emesis)
- skel musc fasciculations–>paralysis
- bradycardia, hypotension, shock
- severe miosis
- CNS stimulation and seizures–>coma
- chronic exposure to some–>demyelination of axons and various neuropathies
tx of acute cholinesterase inhibitor poisoning
- administer high doses atropine (2-4 mg IV initially) followed by 2 mg IM every 10 min until symptoms disappear to block muscarinic receptors
- admin pralidoxime to reactivate enzyme (effective w/ organophosphates only)
- provide additional symptomatic tx as needed (i.e. diazepam for seizures)
major tx uses of cholinesterase inhibitors: myasthenia gravis
dx: endrophonium test
tx: pyridostigmine, neostigmine
MG is AI against nicotinic rec. at motor end plate
Tensilon Test
admin 2-8 mmg edrophonium; improvement in musc. strength suppors myasthenia gravis dx
if musc. wkns worsens: indicative of musc. wkns from exc. doses other cholinesterase inhibitors (cholinergic crisis)
- 5 min duration of action
other (more commonly used) myasthenia gravis dx tests
electromyography (EMG)
serology
cholinesterase inhibitors: tx of glaucoma
cholinergic agonists (acetylcholine, carbachol, pilocarpine) cholinesterase inhibitors (echothiophate) again..these contract ciliary musc-->put tension on trabecular meshwork-->inc. outflow of AH through canal of Schlemm
cholinesterase inhibitors: tx of Alzheimer’s
loss of cholinergic neurons (Nucleus basal is of Meynert)–>raise ACh levels and reverse deficit
tetrahydroaminoacridine (Tacrine)* original, but causes liver damage
rivastigmine (Exelon)
donepezil (Aricept)
galantamine (Reminyl)
other uses of cholinesterase inhibitors
- tx of poisoning by atropine/other antimuscarinic drugs: physostigmine
- reversal of NM blockade by nondepol. NM blockers: neostigmine, pyridostigmine
- tx of atony of bladder or GI tract (i.e.: urine retention, paralytic ileus, etc)
- pyridostigmine used by military to protect against nerve gas: ““pre-exposure antidotal enhancement”